skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:050196/0961   Pages: 14
Recorded: 08/28/2019
Attorney Dkt #:1130558-0147-S216
Conveyance: NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS AND TRADEMARKS
Total properties: 30
1
Patent #:
9597402
Issue Dt:
03/21/2017
Application #:
14701173
Filing Dt:
04/30/2015
Publication #:
US20150231258
Pub Dt:
08/20/2015
Title:
SUSTAINED RELEASE SMALL MOLECULE DRUG FORMULATION
2
Patent #:
10022367
Issue Dt:
07/17/2018
Application #:
15125052
Filing Dt:
09/09/2016
Publication #:
US20170079974
Pub Dt:
03/23/2017
Title:
SUSTAINED-RELEASE BUPRENORPHINE SOLUTIONS
3
Patent #:
10149912
Issue Dt:
12/11/2018
Application #:
15295630
Filing Dt:
10/17/2016
Publication #:
US20170035895
Pub Dt:
02/09/2017
Title:
DEHYDRATED HYDROGEL INCLUSION COMPLEX
4
Patent #:
9782402
Issue Dt:
10/10/2017
Application #:
15334000
Filing Dt:
10/25/2016
Publication #:
US20170079976
Pub Dt:
03/23/2017
Title:
INJECTABLE COMPOSITION COMPRISING BUPRENORPHINE
5
Patent #:
10058554
Issue Dt:
08/28/2018
Application #:
15422626
Filing Dt:
02/02/2017
Publication #:
US20170239252
Pub Dt:
08/24/2017
Title:
SUSTAINED RELEASE SMALL MOLECULE DRUG FORMULATION
6
Patent #:
NONE
Issue Dt:
Application #:
15483769
Filing Dt:
04/10/2017
Publication #:
US20170209431
Pub Dt:
07/27/2017
Title:
SUBLINGUAL AND BUCCAL FILM COMPOSITIONS
7
Patent #:
10000477
Issue Dt:
06/19/2018
Application #:
15522863
Filing Dt:
04/28/2017
Publication #:
US20170334895
Pub Dt:
11/23/2017
Title:
DOPAMINE D3 RECEPTOR ANTAGONIST COMPOUNDS
8
Patent #:
11000520
Issue Dt:
05/11/2021
Application #:
15523986
Filing Dt:
05/03/2017
Publication #:
US20170354653
Pub Dt:
12/14/2017
Title:
BUPRENORPHINE DOSING REGIMENS
9
Patent #:
9827241
Issue Dt:
11/28/2017
Application #:
15623191
Filing Dt:
06/14/2017
Publication #:
US20170281618
Pub Dt:
10/05/2017
Title:
INJECTABLE FLOWABLE COMPOSITION COMPRISING BUPRENORPHINE
10
Patent #:
10273244
Issue Dt:
04/30/2019
Application #:
15750128
Filing Dt:
02/02/2018
Publication #:
US20180222918
Pub Dt:
08/09/2018
Title:
SUBSTITUTED HEXAHYDROPYRROLO[3,4-b]PYRROLES AND HEXAHYDROCYCLOPENTA[c]PYRROLES AS DOPAMINE RECEPTOR MODULATORS
11
Patent #:
NONE
Issue Dt:
Application #:
15763777
Filing Dt:
03/27/2018
Publication #:
US20190046532
Pub Dt:
02/14/2019
Title:
PSYCHIATRIC TREATMENT FOR PATIENTS WITH GENE POLYMORPHISMS
12
Patent #:
10577361
Issue Dt:
03/03/2020
Application #:
15767328
Filing Dt:
04/10/2018
Publication #:
US20180297990
Pub Dt:
10/18/2018
Title:
DOPAMINE D3 RECEPTOR ANTAGONISTS HAVING A MORPHOLINE MOIETY
13
Patent #:
NONE
Issue Dt:
Application #:
15772457
Filing Dt:
04/30/2018
Publication #:
US20180313858
Pub Dt:
11/01/2018
Title:
QUANTIFICATION OF DRUGS IN BIOLOGICAL SAMPLES
14
Patent #:
10558394
Issue Dt:
02/11/2020
Application #:
15820048
Filing Dt:
11/21/2017
Publication #:
US20180157440
Pub Dt:
06/07/2018
Title:
INJECTABLE FLOWABLE COMPOSITION COMPRISING BUPRENORPHINE
15
Patent #:
NONE
Issue Dt:
Application #:
15847548
Filing Dt:
12/19/2017
Publication #:
US20180243292
Pub Dt:
08/30/2018
Title:
SUSTAINED-RELEASE BUPRENORPHINE FORMULATIONS
16
Patent #:
10198218
Issue Dt:
02/05/2019
Application #:
15857507
Filing Dt:
12/28/2017
Publication #:
US20180121137
Pub Dt:
05/03/2018
Title:
INJECTABLE FLOWABLE COMPOSITION COMPRISING BUPRENORPHINE
17
Patent #:
10376590
Issue Dt:
08/13/2019
Application #:
15858525
Filing Dt:
12/29/2017
Publication #:
US20180154001
Pub Dt:
06/07/2018
Title:
SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE COMPOUND
18
Patent #:
NONE
Issue Dt:
Application #:
15889857
Filing Dt:
02/06/2018
Publication #:
US20180161320
Pub Dt:
06/14/2018
Title:
INTRANASAL NALOXONE COMPOSITIONS AND METHODS OF MAKING AND USING SAME
19
Patent #:
10239870
Issue Dt:
03/26/2019
Application #:
15975466
Filing Dt:
05/09/2018
Publication #:
US20180282318
Pub Dt:
10/04/2018
Title:
DOPAMINE D3 RECEPTOR ANTAGONISTS
20
Patent #:
10517864
Issue Dt:
12/31/2019
Application #:
16016186
Filing Dt:
06/22/2018
Publication #:
US20190022085
Pub Dt:
01/24/2019
Title:
SUSTAINED-RELEASE BUPRENORPHINE SOLUTIONS
21
Patent #:
10646484
Issue Dt:
05/12/2020
Application #:
16016250
Filing Dt:
06/22/2018
Publication #:
US20180360821
Pub Dt:
12/20/2018
Title:
METHODS TO TREAT OPIOID USE DISORDER
22
Patent #:
11478407
Issue Dt:
10/25/2022
Application #:
16041170
Filing Dt:
07/20/2018
Publication #:
US20190380909
Pub Dt:
12/19/2019
Title:
SYRINGE SYSTEM
23
Patent #:
10406160
Issue Dt:
09/10/2019
Application #:
16044259
Filing Dt:
07/24/2018
Publication #:
US20180325905
Pub Dt:
11/15/2018
Title:
SUSTAINED RELEASE SMALL MOLECULE DRUG FORMULATION
24
Patent #:
NONE
Issue Dt:
Application #:
16101298
Filing Dt:
08/10/2018
Publication #:
US20190015415
Pub Dt:
01/17/2019
Title:
METHODS FOR TREATING SCHIZOPHRENIA
25
Patent #:
NONE
Issue Dt:
Application #:
16110440
Filing Dt:
08/23/2018
Publication #:
US20180360822
Pub Dt:
12/20/2018
Title:
INTRANASAL NALOXONE COMPOSITIONS AND METHODS OF MAKING AND USING SAME
26
Patent #:
10654842
Issue Dt:
05/19/2020
Application #:
16261206
Filing Dt:
01/29/2019
Publication #:
US20190300514
Pub Dt:
10/03/2019
Title:
DOPAMINE D3 RECEPTOR ANTAGONIST COMPOUNDS
27
Patent #:
10584135
Issue Dt:
03/10/2020
Application #:
16292110
Filing Dt:
03/04/2019
Publication #:
US20190194225
Pub Dt:
06/27/2019
Title:
SUBSTITUTED 3,6-DIAZABICYCLO[3.2.0]HEPTANES
28
Patent #:
11135216
Issue Dt:
10/05/2021
Application #:
16439530
Filing Dt:
06/12/2019
Publication #:
US20200030313
Pub Dt:
01/30/2020
Title:
SUBLINGUAL AND BUCCAL FILM COMPOSITIONS
29
Patent #:
11013809
Issue Dt:
05/25/2021
Application #:
16509287
Filing Dt:
07/11/2019
Publication #:
US20200016270
Pub Dt:
01/16/2020
Title:
SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE COMPOUND
30
Patent #:
11110093
Issue Dt:
09/07/2021
Application #:
16511210
Filing Dt:
07/15/2019
Publication #:
US20200046704
Pub Dt:
02/13/2020
Title:
SUSTAINED RELEASE SMALL MOLECULE DRUG FORMULATION
Assignor
1
INDIVIOR UK LIMITED (FORMERLY KNOWN AS RB PHARMACEUTICALS LIMITED)
Exec Dt:
08/27/2019
Assignee
1
MORGAN STANLEY SENIOR FUNDING INC., AS COLLATERAL AGENT
1300 THAMES STREET, 4TH FLOOR
BALTIMORE, MARYLAND 21231
Correspondence name and address
JUSTINE LU/WHITE & CASE LLP
555 SOUTH FLOWER STREET, 2700
LOS ANGELES, CA 90071

Search Results as of: 06/14/2024 11:49 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT